The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer

被引：24

作者：

Kidane, Biniam ^{[1
]}

Bott, Matthew ^{[2
]}

Spicer, Jonathan ^{[3
]}

Backhus, Leah ^{[4
]}

Chaft, Jamie ^{[2
]}

Chudgar, Neel ^{[5
]}

Colson, Yolonda ^{[6
]}

DAmico, Thomas A. ^{[7
]}

David, Elizabeth ^{[8
]}

Lee, Jay ^{[9
]}

Najmeh, Sara ^{[3
]}

Sepesi, Boris ^{[10
]}

Shu, Catherine ^{[11
]}

Yang, Jeffrey ^{[6
]}

Swanson, Scott ^{[12
]}

Stiles, Brendon ^{[5
,13
]}

机构：

[1] Univ Manitoba, Winnipeg, MB, Canada

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] McGill Univ, Montreal, PQ, Canada

[4] Stanford Univ, Palo Alto, CA USA

[5] Albert Einstein Coll Med, Bronx, NY USA

[6] Massachusetts Gen Hosp, Boston, MA USA

[7] Duke Canc Inst, Durham, NC USA

[8] Univ Colorado, Denver, CO USA

[9] Univ Calif Los Angeles, Los Angeles, CA USA

[10] MD Anderson Canc Ctr, Houston, TX USA

[11] Columbia Univ, New York, NY USA

[12] Brigham & Womens Hosp, Boston, MA USA

[13] Montefiore Med Ctr, Div Thorac Surg, 111 East 210th St, Bronx, NY 10467 USA

来源：

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2023年 / 166卷 / 03期

关键词：

clinical staging; neoadjuvant; adjuvant; immunotherapy; targeted therapy; surgery; non-small cell lung cancer; LYMPH-NODE DISSECTION; TRANSBRONCHIAL NEEDLE ASPIRATION; RESIDUAL TUMOR DESCRIPTORS; CHEMOTHERAPY PLUS SURGERY; ADJUVANT CHEMOTHERAPY; INTERNATIONAL ASSOCIATION; ENDOBRONCHIAL ULTRASOUND; SURGICAL RESECTION; RANDOMIZED-TRIAL; INDUCTION CHEMORADIATION;

D O I：

10.1016/j.jtcvs.2023.04.039

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

引用

页码：637 / 654

页数：18

共 149 条

[1] Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study
Adachi, Hiroyuki
Sakamaki, Kentaro
Nishii, Teppei
Yamamoto, Taketsugu
Nagashima, Takuya
Ishikawa, Yoshihiro
Ando, Kohei
Yamanaka, Kazuki
Watanabe, Katsuya
Kumakiri, Yutaka
Tsuboi, Masahiro
Maehara, Takamitsu
Nakayama, Haruhiko
Masuda, Munetaka
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : 85 - 93
[2] Ak N, 2021, J BUON, V26, P819
[3] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Albain, Kathy S.
Swann, R. Suzanne
Rusch, Valerie W.
Turrisi, Andrew T., III
Shepherd, Frances A.
Smith, Colum
Chen, Yuhchyau
Livingston, Robert B.
Feins, Richard H.
Gandara, David R.
Fry, Willard A.
Darling, Gail
Johnson, David H.
Green, Mark R.
Miller, Robert C.
Ley, Joanne
Sause, Willliam T.
Cox, James D.
[J]. LANCET, 2009, 374 (9687) : 379 - 386
[4] Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
Altorki, Nasser K.
Wang, Xiaofei
Wigle, Dennis
Gu, Lin
Darling, Gail
Ashrafi, Ahmad S.
Landrenau, Rodney
Miller, Daniel
Liberman, Moishe
Jones, David R.
Keenan, Robert
Conti, Massimo
Wright, Gavin
Veit, Linda J.
Ramalingam, Suresh S.
Kamel, Mohamed
Pass, Harvey I.
Mitchell, John D.
Stinchcombe, Thomas
Vokes, Everett
Kohman, Leslie J.
[J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (12) : 915 - 924
[5] Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
Altorki, Nasser K.
Yip, Rowena
Hanaoka, Takaomi
Bauer, Thomas
Aye, Ralph
Kohman, Leslie
Sheppard, Barry
Thurer, Richard
Andaz, Shahriyour
Smith, Michael
Mayfield, William
Grannis, Fred
Korst, Robert
Pass, Harvey
Straznicka, Michaela
Flores, Raja
Henschke, Claudia I.
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (02) : 754 - 762
[6] [Anonymous], 2022, Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer
[7] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J.
Villegas, A.
Daniel, D.
Vicente, D.
Murakami, S.
Hui, R.
Kurata, T.
Chiappori, A.
Lee, K. H.
de Wit, M.
Cho, B. C.
Bourhaba, M.
Quantin, X.
Tokito, T.
Mekhail, T.
Planchard, D.
Kim, Y. -C.
Karapetis, C. S.
Hiret, S.
Ostoros, G.
Kubota, K.
Gray, J. E.
Paz-Ares, L.
Carpeno, J. de Castro
Faivre-Finn, C.
Reck, M.
Vansteenkiste, J.
Spigel, D. R.
Wadsworth, C.
Melillo, G.
Taboada, M.
Dennis, P. A.
Ozguroglu, M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) : 2342 - 2350
[8] Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201
Asamura, Hisao
Hishida, Tomoyuki
Suzuki, Kenji
Koike, Teruaki
Nakamura, Kenichi
Kusumoto, Masahiko
Nagai, Kanji
Tada, Hirohito
Mitsudomi, Tetsuya
Tsuboi, Masahiro
Shibata, Taro
Fukuda, Haruhiko
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (01) : 24 - 30
[9] The American Association for Thoracic Surgery/Society of Thoracic Surgeons position statement on developing clinical practice documents
Bakaeen, Faisal G.
Svensson, Lars G.
Mitchell, John D.
Keshavjee, Shaf
Patterson, G. Alexander
Weisel, Richard D.
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (04) : 999 - 1005
[10] Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Banfill, Kathryn
Giuliani, Meredith
Aznar, Marianne
Franks, Kevin
McWilliam, Alan
Schmitt, Matthias
Sun, Fei
Vozenin, Marie Catherine
Finn, Corinne Faivre
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 216 - 227

← 1 2 3 4 5 6 7 8 9 10 →